tiprankstipranks

Douglas Bratton Insider Profile

4 Followers
Douglas Bratton, Ten Percent Owner at Juno Therapeutics, holds 447.85K shares in Midwest Holding (Ticker: MDWT), holds 1.96M shares in Aquestive Therapeutics (Ticker: AQST), holds 10.08M shares in Denali Therapeutics (Ticker: DNLI).
tipranks
Douglas Bratton

Douglas Bratton
Juno Therapeutics (JUNO)
Ten Percent Owner

Ranked #93,967 out of 97,825 Corporate Insiders

Profitable Transactions

62%
8 out of 13 Profitable Transactions

Average Return

-45.10%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$218M
96.30%
3.70%
A breakdown of Douglas Bratton's holdings

Insider Roles

Denali Therapeutics
(DNLI)
Ten Percent Owner
Aquestive Therapeutics
(AQST)
Ten Percent Owner
Roles that Douglas Bratton holds in companies

Most Profitable Insider Trade

Stock:
Juno Therapeutics
(JUNO)
Rating:Informative Buy
Date:Dec 18, 2014 - Dec 18, 2015
Return:+104.20%
The most profitable trade made by Douglas Bratton

Douglas Bratton's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
JUNO
Juno Therapeutics
Jul 17, 2017
Informative Sell
216.00M
$2.26B
Denali Therapeutics
Feb 17, 2021
Ten Percent Owner
Informative Sell
144.09M
$209.46M
Aquestive Therapeutics
Mar 16, 2021
Ten Percent Owner
Uninformative Buy
$8.04M
MDWT
Midwest Holding
Jun 16, 2022
Uninformative Buy
$12.09M
List of latest transactions for each holding click on a transaction to see Douglas Bratton's performance on stock

Douglas Bratton insider profile FAQ

What is the percentage of profitable transactions made by Douglas Bratton?
The percentage of profitable transactions made by Douglas Bratton is 62%.
    What is the average return per transaction made by Douglas Bratton?
    The average return per transaction made by Douglas Bratton is -45.10%.
      What stocks does Douglas Bratton hold?
      Douglas Bratton holds: JUNO, DNLI, AQST, MDWT stocks.
        What was Douglas Bratton’s latest transaction?
        Douglas Bratton latest transaction was an Uninformative Buy of ―.
          What was Douglas Bratton's most profitable transaction?
          Douglas Bratton’s most profitable transaction was an Informative Buy of JUNO stock on December 18, 2014. The return on the trade was 104.20%.
            What is Douglas Bratton's role in Juno Therapeutics?
            Douglas Bratton's role in Juno Therapeutics is Ten Percent Owner.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.